Bridging the gap between 2024 EULAR/PreS Recommendations for Still’s Disease and practice: the need for awareness of biomarkers and timely use of IL-1/ IL-6 inhibition
The results of the questionnaire applied show that there is still a gap between clinical practice and the recent recommendations, as demonstrated by the underuse of recent biomarkers and biologic therapies, which should be bridged in order to improve health outcomes for individuals affected by SD.
Authors
- Filipa Oliveira‐Ramos (ORCID: https://orcid.org/0000-0001-7132-8909)
- Carolina Zinterl
- Carolina Ochôa Matos
Publication Details
- Journal
- ARP Rheumatology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.63032/nluq9800
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00